Imsidolimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Imsidolimab, covering 2022-05-31 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP [Phase 3]